4826 studies found for:    "Kidney Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
"Kidney Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
Conditions: Chronic Kidney Disease;   Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan (OPC-41061);   Drug: Placebo
2 Completed Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD)
Conditions: Chronic Kidney Disease;   Chronic Kidney Failure;   End Stage Kidney Disease;   End Stage Renal Disease
Intervention: Drug: N-acetylcysteine
3 Completed
Has Results
ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
Conditions: Chronic Kidney Disease;   End Stage Renal Disease;   Coronary Artery Calcification;   Vascular Calcification;   Calcification;   Cardiovascular Disease;   Chronic Renal Failure;   Hyperparathyroidism;   Kidney Disease;   Nephrology;   Secondary Hyperparathyroidism
Intervention: Drug: cinacalcet
4 Completed Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease
Conditions: Radiocontrast-Induced Nephropathy;   Chronic Kidney Disease;   Diabetes Mellitus
Interventions: Drug: N-acetylcysteine;   Drug: Placebo
5 Withdrawn Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects
Conditions: Chronic Kidney Disease;   Kidney Disease
Interventions: Drug: MK-0677;   Drug: Placebo
6 Terminated
Has Results
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
Conditions: Proteinuric Kidney Disease;   Diabetic Nephropathy;   Hypertensive Nephrosclerosis;   IgA Nephropathy;   Focal Segmental Glomerulosclerosis;   Glomerulopathy (Obesity-associated);   Glomerulonephritis, Membranous
Interventions: Drug: Aliskiren;   Drug: Valsartan
7 Completed Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia
Conditions: End Stage Renal Disease;   Chronic Kidney Disease;   Hyperphosphatemic;   Kidney Disease
Interventions: Drug: AMG 223;   Drug: Placebo
8 Completed
Has Results
Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease
Conditions: Diabetes Mellitus;   Chronic Kidney Disease;   Diabetic Kidney Disease
Interventions: Dietary Supplement: Cholecalciferol;   Dietary Supplement: Placebo
9 Active, not recruiting A Study in Patients With Diabetic Kidney Disease
Conditions: Diabetic Kidney Disease;   Diabetic Nephropathy;   Diabetic Glomerulosclerosis
Interventions: Drug: LY2382770;   Drug: Placebo
10 Completed Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease
Conditions: Kidney Disease;   Chronic Kidney Disease
Intervention: Drug: darbepoetin alfa SF
11 Completed Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: RAD001 placebo;   Drug: RAD001
12 Recruiting Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Conditions: Anemia;   Chronic Kidney Disease;   Kidney Disease
Interventions: Drug: darbepoetin alfa QW;   Drug: darbepoetin alfa Q2W
13 Completed START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism
Conditions: Kidney Disease;   Secondary Hyperparathyroidism;   Chronic Kidney Disease
Intervention: Drug: Sensipar
14 Completed Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis
Conditions: Kidney Disease;   Chronic Kidney Disease
Intervention: Drug: Cinacalcet HCl
15 Completed Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis
Conditions: Kidney Disease;   Chronic Kidney Disease
Intervention: Drug: Darbepoetin Alfa
16 Active, not recruiting VA NEPHRON-D: Diabetes iN Nephropathy Study
Conditions: Kidney Disease;   Nephropathy;   Type 2 Diabetes
Interventions: Drug: losartan;   Drug: lisinopril
17 Recruiting Pyridorin in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Diabetic Kidney Disease
Interventions: Drug: Pyridorin;   Drug: Placebo
18 Completed Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function
Conditions: Mild Nephropathy;   Moderate Nephropathy;   Diabetes Mellitus
Intervention: Drug: Technosphere Inhalation Powder
19 Completed Trial for Prevention of Contrast Nephropathy With Sodium Bicarbonate
Conditions: Contrast Induced Nephropathy;   Kidney Diseases
Intervention: Drug: Sodium bicarbonate
20 Completed Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy
Conditions: Contrast Induced Nephropathy;   Kidney Diseases;   Renal Failure;   Adverse Effects
Interventions: Drug: Acetylcysteine;   Drug: Theophylline;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years